TY  - INPR
T1  - The successful use of Suprasorb® C, a collagen wound dressing, on ten patients with mainly severe surgical wounds
T5  - Poster presented at WUWHS 2004
LA  - English
AU  - Boom, M.
AU  - Vijverberg, A.
AU  - Vijverberg, L.
AB  - Introduction:
Regarding the years of successful use Suprasorb® C of Lohmann & Rauscher (a special wound dressing composed of collagen type I), we performed a case study on nine patients with very large and mainly surgical wounds of a severe nature. The purpose was to demonstrate the effective and practical use of collagen dressings in these cases.

Methods
Descriptive investigation by determined criteria, put in a special form, was used to document the treatment as detailed as possible.

Results:
The average age of the patients was 60 years. Four of them had a postoperative wound disturbance in the abdominal area. A surgical removing of debris had been executed on 3 patients. Maggots were used on one patient to clean the wound area. In a single case honey and silver dressings were used to cure infections. Because of an extremely large wound in four cases, vacuum sealing was used to initiate wound closure. We used modern wound care products of the Suprasorb® line around the tenth day of treatment. In seven cases we applied firstly the alginate in order to clean the wound furthermore. We resumed treatment with collagen (Suprasorb® C) in all nine cases to accelerate the healing process of the wound. Foil and foam wound dressings were used additionally as secondary wound dressings to cover up the wound. Additional therapy was not necessary. The average wound surface at the beginning of the treatment was 101,5 cm2. At the end, it had been decreased to an average of 2,8 cm2 in 76 days, which meant a reduction of 97,2%.

Conclusions
Suprasorb® C is a patient-friendly and effective wound care product to heal secondary healing wounds eg severe surgical wounds. Further investigation concerning the duration of the wound healing process in comparison to conventional wound treatment is advisory.
CY  - Paris, France
Y2  - 1089237600
ER  -